In vivo imaging of oligonucleotides with positron emission tomography
- 1 April 1998
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 4 (4), 467-471
- https://doi.org/10.1038/nm0498-467
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cellsNucleic Acids Research, 1997
- A Specificity Comparison of Four Antisense Types: Morpholino, 2′-O-Methyl RNA, DNA, and Phosphorothioate DNAAntisense and Nucleic Acid Drug Development, 1997
- The imaging science of positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Biodistribution of iodine-125 tyramine transforming growth factor ? antisense oligonucleotide in athymic mice with a human mammary tumour xenograft following intratumoral injectionEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- The role of positron emission tomography within the spectrum of medical imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotidesJournal of Clinical Laboratory Analysis, 1995
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Concentrated, digestible DNA after hydroxylapatite chromatography with cetylpyridinium bromide precipitationAnalytical Biochemistry, 1983
- Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.Proceedings of the National Academy of Sciences, 1978